The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma-Reference-Cited by-同舟云学术

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

Published:2005-05-13 Issue:12 Volume:18 Page:1591-1598
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Yamauchi Naoko,Watanabe Akira,Hishinuma Michiyo,Ohashi Ken-ichi,Midorikawa Yutaka,Morishita Yasuyuki,Niki Toshiro,Shibahara Junji,Mori Masaya,Makuuchi Masatoshi,Hippo Yoshitaka,Kodama Tatsuhiko,Iwanari Hiroko,Aburatani Hiroyuki,Fukayama Masashi

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800436.pdf

Reference24 articles.

1. Schafer DF, Sorrell MF . Hepatocellular carcinoma. Lancet 1999;353:1253–1257.

2. Okuda K . Hepatocellular carcinoma. J Hepatol 2000;32:225–237.

3. Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal ‘capillarization’ in dysplastic nodules of the liver. Am J Surg Pathol 1998;22:656–662.

4. Kong CS, Appenzeller M, Ferrell LD . Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy. Acta Cytol 2000;44:218–222.

5. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978–988.

Cited by 285 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma;Biochemistry and Biophysics Reports;2024-09

2. Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma;Molecular Therapy: Oncology;2024-06

3. Gastric adenocarcinoma with enteroblastic differentiation in a 67-year-old man in Korea: a case report;The Ewha Medical Journal;2024-04-30

4. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy;Nature Cancer;2024-01-02

5. Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation;American Journal of Cancer Research;2024